(Q41071697)

26 September 2017

1 reference

title

Apolipoproteins: pathophysiology and clinical implications (English)

1 reference

26 September 2017

Patsch W

1

1 reference

PubMed ID

8748998

26 September 2017

Gotto AM Jr

series ordinal

2

1 reference

PubMed ID

8748998

26 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

26 September 2017

Methods in Enzymology

1 reference

26 September 2017

263

1 reference

26 September 2017

3-32

1 reference

A molecular theory of lipid-protein interactions in the plasma lipoproteins

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Repeated helical pattern in apolipoprotein-A-I

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Structure and evolution of the apolipoprotein multigene family

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

DNA sequence of the human apolipoprotein B gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Transcriptional interference and termination between duplicated alpha-globin gene constructs suggests a novel mechanism for gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Analysis of avian leukosis virus DNA and RNA in bursal tumors: Viral gene expression is not required for maintenance of the tumor state

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Thyroid hormone influences the maturation of apolipoprotein A-I messenger RNA in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Site-specific creation of uridine from cytidine in apolipoprotein B mRNA editing

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein B mRNA sequences 3' of the editing site are necessary and sufficient for editing and editosome assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein B mRNA editing: a new tier for the control of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

RNA editing in brain controls a determinant of ion flow in glutamate-gated channels

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Molecular cloning of an apolipoprotein B messenger RNA editing protein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Regulation of intestinal and hepatic apoprotein synthesis after chronic fat and cholesterol feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Role of insulin in lipoprotein secretion by cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

New variation on the translocation of proteins during early biogenesis of apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Pause transfer: a topogenic sequence in apolipoprotein B mediates stopping and restarting of translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A protein cofactor of lecithin:cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin. Cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Variant apolipoprotein AI as a major constituent of a human hereditary amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Sequence and expression of Tangier apoA-I gene

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

High density lipoprotein deficiency syndrome in chickens is not associated with an increased susceptibility to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein A-I containing lipoproteins in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Cloning of a complementary deoxyribonucleic acid encoding a portion of rat intestinal preapolipoprotein AIV messenger ribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Effect of sucrose diet on expression of apolipoprotein genes A-I, C-III and A-IV in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Altered regulation of apolipoprotein A-IV gene expression in the liver of the genetically obese Zucker rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

The mutation causing the common apolipoprotein A-IV polymorphism is a glutamine to histidine substitution of amino acid 360

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Complete protein sequence and identification of structural domains of human apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Recent progress in understanding apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Heritable allele-specific differences in amounts of apoB and low-density lipoproteins in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Detection and characterization of the heterozygote state for lipoprotein lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Plasma triglyceride determines structure-composition in low and high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein C-1 inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A specific apoprotein activator for lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-II

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

DNA POLYMORPHISM ADJACENT TO HUMAN APOPROTEIN A-1 GENE: RELATION TO HYPERTRIGLYCERIDAEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Abnormal in vivo metabolism of apolipoprotein E4 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Beta 2-glycoprotein-1 (apolipoprotein H) excretion in chronic renal tubular disorders: comparison with other protein markers of tubular malfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Detection and quantitation of apolipoprotein(a) mRNA in human liver and its relationship with plasma lipoprotein(a) concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Intracellular processing of apo(a) in primary baboon hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a))

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Interaction of lipoprotein(a) with fibronectin and its potential role in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Oxidative modification of lipoprotein(a) and the effect of beta-carotene

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Probucol protects lipoprotein (a) against oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

A potential basis for the thrombotic risks associated with lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Regulation of PGI2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGI2 binding and stabilizing protein in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Polymorphism at the apoprotein-E locus in relation to risk of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

Lipoprotein(a) in diet-induced atherosclerosis in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2963003-1

7 January 2021

10.1016/S0076-6879(96)63003-1

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8748998